Anticonvulsant effects of bis-1,4-dihydropyridines and the probable role of L-type calcium channels suggested by docking simulations

作者: Eduardo Ramírez-San Juan , Marvin A. Soriano-Ursúa , Judith Espinosa-Raya , José Correa-Basurto , José G. Trujillo-Ferrara

DOI: 10.1007/S00044-014-1083-0

关键词:

摘要: The influx/efflux of calcium (Ca2+) ions through channels in cellular membranes plays a pivotal role many physiological and physiopathological processes. Among these are those involved the physiopathology epileptic seizures. Hence, control permeability is considered strategy for development anticonvulsant drugs. According to previous reports, dihydropyridine derivatives have proven be Ca2+ channel blockers anticonvulsive properties, presumably by means their action on L-type (LCCs). aim present study was determine effects four bis-1,4-dihydropyridines (bis-DHPs) male CF1 mice (25–30 g bw) using two experimental models: maximal electroshock (MES, which induces convulsions with an alternating current 60 Hz) pentylenetetrazole administration (PTZ, 90 mg/kg administered i.p.). Additionally, binding mode explored docking 3-D model LCC. bis-DHPs herein tested showed protective effect relation number induced MES, recovery time after convulsion, duration tonic phase. However, only 01–03 reduced clonic phase, compounds also produced significant against PTZ administration. This may related interaction cluster aromatic residues (Tyr1152, Tyr1463, Phe1159) blocking flow, as suggested studies.

参考文章(50)
Ahmet Doğrul, I. Tayfun Uzbay, Özgür Yeşilyurt, Differential Effects of Systemic Versus Central Routes ofAdministration of L-Type Calcium Channel Blockers onPentylenetetrazole-Induced Seizures in Mice - Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology. ,vol. 15, pp. 153- 157 ,(2005)
Jarogniew J Luszczki, Kinga K Borowicz, Michał K Trojnar, Stanisław J Czuczwar, Anna Zadrozniak, Marcin P Trojnar, Zaneta Kimber-Trojnar, Beata Szostakiewicz, Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model. Pharmacological Reports. ,vol. 59, pp. 672- 682 ,(2007)
Wojciech Sobaniec, Wojciech Kulak, Stanislaw J. Czuczwar, Katarzyna Wojtal, Calcium modulation in epilepsy. Polish Journal of Pharmacology. ,vol. 56, pp. 29- 41 ,(2004)
Kristina A. Simeone, Shivkumar Sabesan, Do Young Kim, John F. Kerrigan, Jong M. Rho, Timothy A. Simeone, L-Type calcium channel blockade reduces network activity in human epileptic hypothalamic hamartoma tissue. Epilepsia. ,vol. 52, pp. 531- 540 ,(2011) , 10.1111/J.1528-1167.2010.02942.X
Mohammad Hasan, Jennifer Pulman, Anthony G Marson, Calcium antagonists as an add-on therapy for drug-resistant epilepsy. Cochrane Database of Systematic Reviews. ,(2013) , 10.1002/14651858.CD002750.PUB2
Eduardo Ramírez-San Juan, José Trujillo, René Miranda, Gabriel Arroyo, Raquel Gómez-Pliego, Raquel Gómez-Pliego, Isai Zamora, Francisco Delgado, Roberto Osnaya, Roberto Osnaya, Benjamín Velasco-Bejarano, The Hantzsch Ester Production in a Water-based Biphasic Medium, Using Infrared Irradiation as the Activating Source Revista de la Sociedad Química de Mexico. ,vol. 51, pp. 181- 184 ,(2007)
Maciej Gasior, Kinga Borowicz, ZDZISŁAW Kleinrok, RADOSŁAW Starownik, STANISŁAW J Czuczwar, Anticonvulsant and Adverse Effects of MK-801, LY 235959, and GYKI 52466 in Combination with Ca2+ Channel Inhibitors in Mice Pharmacology Biochemistry and Behavior. ,vol. 56, pp. 629- 635 ,(1997) , 10.1016/S0091-3057(96)00405-4
Irene HUBER, Edwin WAPPL, Alexander HERZOG, Jörg MITTERDORFER, Hartmut GLOSSMANN, Thierry LANGER, Jörg STRIESSNIG, Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochemical Journal. ,vol. 347, pp. 829- 836 ,(2000) , 10.1042/BJ3470829
Emilio Russo, Andrew Constanti, Guido Ferreri, Rita Citraro, Giovambattista De Sarro, Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology. ,vol. 46, pp. 865- 878 ,(2004) , 10.1016/J.NEUROPHARM.2003.11.028